Trichinellosis
ORPHA:863DiseaseNot applicableAll ages
Фенотипы (HPO)42
Частый (30–79%)9
HP:0000282Facial edema
HP:0000969Edema
HP:0001265Hyporeflexia
HP:0001324Muscle weakness
HP:0002018Nausea
HP:0003212Increased circulating IgE level
HP:0003457EMG abnormality
HP:0030953Conjunctival hyperemia
HP:0100539Periorbital edema
Периодический (5–29%)21
HP:0000211Trismus
HP:0000360Tinnitus
HP:0000496Abnormality of eye movement
HP:0000509Conjunctivitis
HP:0000602Ophthalmoplegia
HP:0000708Atypical behavior
HP:0000737Irritability
HP:0000741Apathy
HP:0000988Skin rash
HP:0001254Lethargy
HP:0001262Excessive daytime somnolence
HP:0001269Hemiparesis
HP:0001289Confusion
HP:0001626Abnormality of the cardiovascular system
HP:0002015Dysphagia
HP:0002321Vertigo
HP:0002354Memory impairment
HP:0002921Abnormality of the cerebrospinal fluid
HP:0004372Reduced consciousness/confusion
HP:0005986Limitation of neck motion
HP:0200026Ocular pain
Очень редкий (1–4%)12
HP:0000553Abnormal uvea morphology
HP:0000573Retinal hemorrhage
HP:0000587Abnormal optic nerve morphology
HP:0000651Diplopia
HP:0001287Meningitis
HP:0001298Encephalopathy
HP:0002301Hemiplegia
HP:0002381Aphasia
HP:0003487Babinski sign
HP:0009916Anisocoria
HP:0010628Facial palsy
HP:0025342Central retinal artery occlusion
Эпидемиология10
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | Unknown | — | Europe | Class only |
| Annual incidence | <1 / 1 000 000 | 0.06 | Europe | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.48 | Bulgaria | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.067 | Croatia | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.04 | Estonia | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.04 | Italy | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.06 | Latvia | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.6 | Lithuania | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.64 | Romania | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.08 | Slovakia | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)